Straub RH, Cutolo M: Circadian rhythms in rheumatoid arthritis: implications for pathophysiology and therapeutic management. Arthritis Rheum. 2007, 56: 399-408. 10.1002/art.22368.
Article
PubMed
Google Scholar
Spies CM, Cutolo M, Straub RH, Burmester GR, Buttgereit F: More night than day - circadian rhythms in polymyalgia rheumatica and ankylosing spondylitis. J Rheumatol. 2010, 37: 894-899. 10.3899/jrheum.091283.
Article
PubMed
Google Scholar
Sierakowski S, Cutolo M: Morning symptoms in rheumatoid arthritis: a defining characteristic and marker of active disease. Scand J Rheumatol Suppl. 2011, 125: 1-5.
Article
CAS
PubMed
Google Scholar
Straub RH, Bijlsma JW, Masi A, Cutolo M: Role of neuroendocrine and neuroimmune mechanisms in chronic inflammatory rheumatic diseases - the 10-year update. Semin Arthritis Rheum. 2013, 43: 392-404. 10.1016/j.semarthrit.2013.04.008.
Article
CAS
PubMed
Google Scholar
Cutolo M: Chronobiology and the treatment of rheumatoid arthritis. Curr Opin Rheumatol. 2012, 24: 312-318. 10.1097/BOR.0b013e3283521c78.
Article
CAS
PubMed
Google Scholar
Cutolo M: Rheumatoid arthritis: circadian and circannual rhythms in RA. Nat Rev Rheumatol. 2011, 7: 500-502. 10.1038/nrrheum.2011.115.
Article
PubMed
Google Scholar
Cutolo M, Straub RH, Bijlsma JW: Neuroendocrine-immune interactions in synovitis. Nat Clin Pract Rheumatol. 2007, 3: 627-634. 10.1038/ncprheum0601.
Article
CAS
PubMed
Google Scholar
Straub RH, Gluck T, Cutolo M, Georgi J, Helmke K, Scholmerich J, Vaith P, Lang B: The adrenal steroid status in relation to inflammatory cytokines (interleukin-6 and tumour necrosis factor) in polymyalgia rheumatica. Rheumatology. 2000, 39: 624-631. 10.1093/rheumatology/39.6.624.
Article
CAS
PubMed
Google Scholar
Cutolo M, Foppiani L, Minuto F: Hypothalamic-pituitary-adrenal axis impairment in the pathogenesis of rheumatoid arthritis and polymyalgia rheumatica. J Endocrinol Invest. 2002, 25: 19-23. 10.1007/BF03345073.
Article
CAS
PubMed
Google Scholar
Caporali R, Cimmino MA, Montecucco C, Cutolo M: Glucocorticoid treatment of polymyalgia rheumatica. Clin Exp Rheumatol. 2011, 29: S143-S147.
CAS
PubMed
Google Scholar
Bollinger T, Bollinger A, Naujoks J, Lange T, Solbach W: The influence of regulatory T cells and diurnal hormone rhythms on T helper cell activity. Immunology. 2010, 131: 488-500. 10.1111/j.1365-2567.2010.03320.x.
Article
PubMed Central
CAS
PubMed
Google Scholar
Crofford LJ, Kalogeras KT, Mastorakos G, Magiakou MA, Wells J, Kanik KS, Gold PW, Chrousos GP, Wilder RL: Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. J Clin Endocrinol Metab. 1997, 82: 1279-1283. 10.1210/jcem.82.4.3852.
Article
CAS
PubMed
Google Scholar
Straub RH, Paimela L, Peltomaa R, Scholmerich J, Leirisalo-Repo M: Inadequately low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis. Arthritis Rheum. 2002, 46: 654-662. 10.1002/art.10177.
Article
CAS
PubMed
Google Scholar
Steensberg A, Fischer CP, Sacchetti M, Keller C, Osada T, Schjerling P, van Hall G, Febbraio MA, Pedersen BK: Acute interleukin-6 administration does not impair muscle glucose uptake or whole-body glucose disposal in healthy humans. J Physiol. 2003, 548: 631-638. 10.1113/jphysiol.2002.032938.
Article
PubMed Central
CAS
PubMed
Google Scholar
Tsigos C, Papanicolaou DA, Defensor R, Mitsiadis CS, Kyrou I, Chrousos GP: Dose effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure. Neuroendocrinology. 1997, 66: 54-62. 10.1159/000127219.
Article
CAS
PubMed
Google Scholar
Mastorakos G, Chrousos GP, Weber JS: Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab. 1993, 77: 1690-1694.
CAS
PubMed
Google Scholar
Smolen JS, Landewe R, Breedveld FC, Buch M, Burmester G, Dougados M, Emery P, Gaujoux-Viala C, Gossec L, Nam J, Ramiro S, Winthrop K, de Wit M, Aletaha D, Betteridge N, Bijlsma JW, Boers M, Buttgereit F, Combe B, Cutolo M, Damjanov N, Hazes JM, Kouloumas M, Kvien TK, Mariette X, Pavelka K, van Riel PL, Rubbert-Roth A, Scholte-Voshaar M, Scott DL: EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis. 2014, 73: 492-509.
Article
PubMed Central
CAS
PubMed
Google Scholar
Buttgereit F: Do the treatment with glucocorticoids and/or the disease itself drive the impairment in glucose metabolism in patients with rheumatoid arthritis?. Ann Rheum Dis. 2011, 70: 1881-1883. 10.1136/annrheumdis-2011-200388.
Article
CAS
PubMed
Google Scholar
Narvaez J, Bernad B, Diaz Torne C, Momplet JV, Montpel JZ, Nolla JM, Valverde-Garcia J: Low serum levels of DHEAS in untreated polymyalgia rheumatica/giant cell arteritis. J Rheumatol. 2006, 33: 1293-1298.
CAS
PubMed
Google Scholar
Edwards C: Sixty years after Hench - corticosteroids and chronic inflammatory disease. J Clin Endocrinol Metab. 2012, 97: 1443-1451. 10.1210/jc.2011-2879.
Article
CAS
PubMed
Google Scholar
Charmandari E, Nicolaides NC, Chrousos GP: Adrenal insufficiency. Lancet. 2014, 383: 2152-2167. 10.1016/S0140-6736(13)61684-0.
Article
CAS
PubMed
Google Scholar
Kaiser H, Kley HK: Cortisontherapie. 2002, Stuttgart: Thieme Georg Verlag
Book
Google Scholar
Harbuz MS, Korendowych E, Jessop DS, Crown AL, Li pdfan SL, Kirwan JR: Hypothalamo-pituitary-adrenal axis dysregulation in patients with rheumatoid arthritis after the dexamethasone/corticotrophin releasing factor test. J Endocrinol. 2003, 178: 55-60. 10.1677/joe.0.1780055.
Article
CAS
PubMed
Google Scholar
Henzen C, Suter A, Lerch E, Urbinelli R, Schorno XH, Briner VA: Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment. Lancet. 2000, 355: 542-545. 10.1016/S0140-6736(99)06290-X.
Article
CAS
PubMed
Google Scholar
Klinefelter HF, Winkenwerder WL, Bledsoe T: Single daily dose prednisone therapy. JAMA. 1979, 241: 2721-2723. 10.1001/jama.1979.03290510029021.
Article
CAS
PubMed
Google Scholar
Kirwan JR, Hickey SH, Hallgren R, Mielants H, Bjorck E, Persson T, Wollheim FA: The effect of therapeutic glucocorticoids on the adrenal response in a randomized controlled trial in patients with rheumatoid arthritis. Arthritis Rheum. 2006, 54: 1415-1421. 10.1002/art.21747.
Article
CAS
PubMed
Google Scholar
Jasani MK, Diver MJ, Bell AM, Dalakos TG, Buchanan WW: Some clinical observations on the diurnal rhythm of plasma cortisol (11-OHCS) in patients with rheumatoid arthritis treated with oral corticosteroid drugs. Curr Med Res Opin. 1974, 2: 373-386. 10.1185/03007997409112653.
Article
CAS
PubMed
Google Scholar
Grant SD, Forsham PH, DiRaimondo VC: Suppression of 17-hydroxycorticosteroids in plasma and urine by single and divided doses of triamcinolone. N Engl J Med. 1965, 273: 1115-1118. 10.1056/NEJM196511182732101.
Article
CAS
PubMed
Google Scholar
Haus E, Sackett-Lundeen L, Smolensky MH: Rheumatoid arthritis: circadian rhythms in disease activity, signs and symptoms, and rationale for chronotherapy with corticosteroids and other medications. Bull NYU Hosp Jt Dis. 2012, 70 (Suppl 1): 3-10.
PubMed
Google Scholar
Angeli A: Circadian ACTH-adrenal rhythm in man. Chronobiologia. 1974, 1 (Suppl 1): 253-270.
PubMed
Google Scholar
Nichols T, Nugent CA, Tyler FH: Diurnal variation in suppression of adrenal function by glucocorticoids. J Clin Endocrinol Metab. 1965, 25: 343-349. 10.1210/jcem-25-3-343.
Article
CAS
PubMed
Google Scholar
Di Raimondo VC, Forsham PH: Some clinical implications of the spontaneous diurnal variation in adrenal cortical secretory activity. Am J Med. 1956, 21: 321-323. 10.1016/0002-9343(56)90033-X.
Article
CAS
PubMed
Google Scholar
Di Raimondo VC, Forsham PH: Pharmacophysiologic principles in the use of corticoids and adrenocorticotropin. Metabolism. 1958, 7: 5-24.
CAS
Google Scholar
Deandrade JR, McCormick JN, Hill AG: Small doses of prednisolone in the management of rheumatoid arthritis. Ann Rheum Dis. 1964, 23: 158-162. 10.1136/ard.23.2.158.
Article
CAS
PubMed
Google Scholar
Smolensky MH, Peppas NA: Chronobiology, drug delivery, and chronotherapeutics. Adv Drug Deliv Rev. 2007, 59: 828-851. 10.1016/j.addr.2007.07.001.
Article
CAS
PubMed
Google Scholar
Myles AB, Schiller LF, Glass D, Daly JR: Single daily dose corticosteroid treatment. Ann Rheum Dis. 1976, 35: 73-76. 10.1136/ard.35.1.73.
Article
PubMed Central
CAS
PubMed
Google Scholar
De AJ: Pituitary-adrenocortical reserve during corticosteroid therapy: a report on the methopyrapone test in ten patients taking long-continued small doses. J Clin Endocrinol Metab. 1964, 24: 261-262. 10.1210/jcem-24-3-261.
Article
Google Scholar
Reinberg A, Guillet P, Gervais P, Ghata J, Vignaud D, Abulker C: One month chronocorticotherapy (Dutimelan 8 15 mite). Control of the asthmatic condition without adrenal suppression and circadian rhythm alteration. Chronobiologia. 1977, 4: 295-312.
CAS
PubMed
Google Scholar
McAllister WA, Mitchell DM, Collins JV: Prednisolone pharmacokinetics compared between night and day in asthmatic and normal subjects. Br J Clin Pharmacol. 1981, 11: 303-304. 10.1111/j.1365-2125.1981.tb00538.x.
Article
PubMed Central
CAS
PubMed
Google Scholar
Masi AT, Chrousos GP: Dilemmas of low dosage glucocorticoid treatment in rheumatoid arthritis: considerations of timing. Ann Rheum Dis. 1997, 56: 1-4. 10.1136/ard.56.1.1.
Article
PubMed Central
CAS
PubMed
Google Scholar
Arvidson NG, Gudbjornsson B, Larsson A, Hallgren R: The timing of glucocorticoid administration in rheumatoid arthritis. Ann Rheum Dis. 1997, 56: 27-31. 10.1136/ard.56.1.27.
Article
PubMed Central
CAS
PubMed
Google Scholar
De Silva M, Binder A, Hazleman BL: The timing of prednisolone dosage and its effect on morning stiffness in rheumatoid arthritis. Ann Rheum Dis. 1984, 43: 790-793. 10.1136/ard.43.6.790.
Article
PubMed Central
CAS
PubMed
Google Scholar
Owlia MB, Mehrpoor G, Modares Mosadegh M: Bedtime single-dose prednisolone in clinically stable rheumatoid arthritis patients. ISRN Pharmacol. 2012, 2012: 637204-
PubMed
Google Scholar
Karatay S, Senel K, Ugur M, Yildirim K: The timing of low dose glucocorticoid therapy in treatment of rheumatoid arthritis. Pain Clinic. 2002, 13: 305-312. 10.1163/15685690260138910.
Article
Google Scholar
Kowanko IC, Pownall R, Knapp MS, Swannell AJ, Mahoney PG: Circadian variations in the signs and symptoms of rheumatoid arthritis and in the therapeutic effectiveness of flurbiprofen at different times of day. Br J Clin Pharmacol. 1981, 11: 477-484. 10.1111/j.1365-2125.1981.tb01153.x.
Article
PubMed Central
CAS
PubMed
Google Scholar
Buttgereit F, Doering G, Schaeffler A, Witte S, Sierakowski S, Gromnica-Ihle E, Jeka S, Krueger K, Szechinski J, Alten R: Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial. Lancet. 2008, 371: 205-214. 10.1016/S0140-6736(08)60132-4.
Article
CAS
PubMed
Google Scholar
Buttgereit F, Doering G, Schaeffler A, Witte S, Sierakowski S, Gromnica-Ihle E, Jeka S, Krueger K, Szechinski J, Alten R: Targeting pathophysiological rhythms: prednisone chronotherapy shows sustained efficacy in rheumatoid arthritis. Ann Rheum Dis. 2010, 69: 1275-1280. 10.1136/ard.2009.126888.
Article
PubMed Central
CAS
PubMed
Google Scholar
Alten R, Doring G, Cutolo M, Gromnica-Ihle E, Witte S, Straub R, Buttgereit F: Hypothalamus-pituitary-adrenal axis function in patients with rheumatoid arthritis treated with nighttime-release prednisone. J Rheumatol. 2010, 37: 2025-2031. 10.3899/jrheum.100051.
Article
PubMed
Google Scholar
Clarke L, Jessop DS, Hunt LP, Straub RH, Perry MG, Kirwan J: Alleviation of morning joint stiffness by low-dose prednisone in rheumatoid arthritis is associated with circadian changes in IL-6 and cortisol. Int J Clin Rheumatol. 2011, 6: 241-249. 10.2217/ijr.11.12.
Article
CAS
Google Scholar